Association of Traditional Chinese Medicine Therapy and the Risk of Vascular Complications in Patients With Type II Diabetes Mellitus: A Nationwide, Retrospective, Taiwanese-Registry, Cohort Study

Ai-Lin Lee, Bor-Chyuan Chen, Chih-Hsin Mou, Mao-Feng Sun, Hung-Rong Yen, Ai-Lin Lee, Bor-Chyuan Chen, Chih-Hsin Mou, Mao-Feng Sun, Hung-Rong Yen

Abstract

With an increasing use of traditional Chinese medicine (TCM) in type 2 diabetes mellitus (T2DM), evidence of long-term benefit with adjunctive TCM treatment is limited. This study investigated whether the concurrent TCM treatment reduces the risk of vascular complications in T2DM patients by using a large population from National Health Insurance Research Database (NHIRD).We identified 33,457 adult patients with newly diagnosed T2DM using anti-diabetic agents from a random sample of one million beneficiaries in the NHIRD between January 1, 2000 and December 31, 2011. We recruited 1049 TCM users (received TCM over 30 days with a diagnosis of T2DM) and randomly selected 4092 controls as the non-TCM cohort at a ratio of 1:4 frequency-matched by age, sex, hypertension, hyperlipidemia, and index year. We investigated the prescription pattern of TCM and conducted a Cox proportional hazards regression to calculate the hazard ratios (HRs) of stroke, chronic kidney diseases (CKD), and diabetic foot between the 2 cohorts.In the TCM cohort, the prescription pattern of TCM was different between insulin and noninsulin patients. The most common herbs were Dan-Shen (Radix Salviae Miltiorrhizae) in noninsulin group and Da-Huang (Radix et Rhizoma Rhei) in insulin group. The most common formulae were Liu-Wei-Di-Huang-Wan in noninsulin group and Yu-Quan-Wan in insulin group. Although no significant reduction in the hazard ratio of CKD and diabetic foot, the incidence rate of stroke was 7.19 per 1000 person-years in the TCM cohort and 10.66 per 1000 person-years in the control cohort, respectively. After adjustment of age, sex, hypertension, hyperlipidemia, and antidiabetes agent use (including sulfonylureas, α-glucosidase, metformin, meglitinide, thiazolidinediones, and insulin), TCM cohorts were found to have a 33% decreased risk of stroke (95% CI = 0.46-0.97; P < 0.05).This population-based retrospective study showed that the complementary TCM therapy might associate with the decreased risk of stroke in T2DM, suggesting TCM as an adjunctive therapy for T2DM to prevent subsequent stroke.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Flow recruitment chart of newly diagnosed type 2 diabetes mellitus patients from a random sample of 1 million individuals from the National Health Insurance Research Database in Taiwan. NHIRD = National Health Insurance Research Database; T2DM = type 2 diabetes mellitus; TCM = traditional Chinese medicine.

References

    1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047–1053.
    1. Stolar M. Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010; 123 (3 Suppl):S3–S11.
    1. Huang CY, Tsai YT, Lai JN, et al. Prescription pattern of Chinese herbal products for diabetes mellitus in Taiwan: a population-based study. Evid Based Complement Alternat Med 2013; 2013:201329.
    1. Huang CY, Lai WY, Sun MF, et al. Prescription patterns of traditional Chinese medicine for peptic ulcer disease in Taiwan: a nationwide population-based study. J Ethnopharmacol 2015; 176:311–320.
    1. Huang MC, Pai FT, Lin CC, et al. Characteristics of traditional Chinese medicine use in patients with rheumatoid arthritis in Taiwan: a nationwide population-based study. J Ethnopharmacol 2015; 176:9–16.
    1. Yen HR, Liang KL, Huang TP, et al. Characteristics of traditional Chinese medicine use for children with allergic rhinitis: a nationwide population-based study. Int J Pediatr Otorhinolaryngol 2015; 79:591–597.
    1. Introduction to the National Health Insurance Research Database (NHIRD), Taiwan. Accessed [Dec 19, 2015]
    1. Feng S, Song L, Liu Y, et al. Hypoglycemic activities of commonly-used traditional Chinese herbs. Am J Chin Med 2013; 41:849–864.
    1. Hui H, Tang G, Go VL. Hypoglycemic herbs and their action mechanisms. Chin Med 2009; 4:11.
    1. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11:98–107.
    1. Haffner SM. Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract 2003; 61:S9–S18.
    1. Murray KN, Buggey HF, Denes A, et al. Systemic immune activation shapes stroke outcome. Mol Cell Neurosci 2013; 53:14–25.
    1. Fan GW, Gao XM, Wang H, et al. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS. J Steroid Biochem Mol Biol 2009; 113:275–280.
    1. Zhang R, Zhou J, Jia Z, et al. Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism. J Ethnopharmacol 2004; 90:39–43.
    1. Hartog A, Hougee S, Faber J, et al. The multicomponent phytopharmaceutical SKI306X inhibits in vitro cartilage degradation and the production of inflammatory mediators. Phytomedicine 2008; 15:313–320.
    1. Ryu M, Kim EH, Chun M, et al. Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk. J Ethnopharmacol 2008; 115:184–193.
    1. Oke SL, Tracey KJ. The inflammatory reflex and the role of complementary and alternative medical therapies. Ann N Y Acad Sci 2009; 1172:172–180.
    1. Xie W, Du L. Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 2011; 12:289–301.
    1. Santulli G, Pagano G, Sardu C, et al. Calcium release channel RyR2 regulates insulin release and glucose homeostasis. J Clin Invest 2015; 125:1968–1978.
    1. Hu J, Li YL, Li ZL, et al. Chronic supplementation of paeonol combined with danshensu for the improvement of vascular reactivity in the cerebral basilar artery of diabetic rats. Int J Mol Sci 2012; 13:14565–14578.
    1. Yang GD, Zhang H, Lin R, et al. Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells. Basic Clin Pharmacol Toxicol 2009; 104:87–92.
    1. Xue J, Ding W, Liu Y. Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice. Fitoterapia 2010; 81:173–177.
    1. Feng Y, Huang SL, Dou W, et al. Emodin, a natural product, selectively inhibits 11beta-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice. Br J Pharmacol 2010; 161:113–126.
    1. Poon TY, Ong KL, Cheung BM. Review of the effects of the traditional Chinese medicine Rehmannia Six Formula on diabetes mellitus and its complications. J Diabetes 2011; 3:184–200.
    1. van Wietmarschen HA, van der Greef J, Schroen Y, et al. Evaluation of symptom, clinical chemistry and metabolomics profiles during Rehmannia six formula (R6) treatment: an integrated and personalized data analysis approach. J Ethnopharmacol 2013; 150:851–859.
    1. Hirotani Y, Ikeda K, Myotoku M. Effects of the herbal medicine Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on insulin secretion and glucose tolerance in type 2 diabetic Goto-Kakizaki rats. Drug Discov Ther 2010; 4:129–134.
    1. Hirotani Y, Ikeda T, Yamamoto K, et al. Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on hyperglycemia in streptozotocin-induced diabetic rats. Biol Pharm Bull 2007; 30:1015–1020.
    1. Hirotani Y, Ikeda T, Ikeda K, et al. Effects of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on intestinal function in streptozotocin-induced diabetic rats. Yakugaku Zasshi 2007; 127:1509–1513.
    1. Kim HY, Yokozawa T, Cho EJ, et al. Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress. J Pharm Pharmacol 2004; 56:1299–1305.
    1. Yamabe N, Yokozawa T. Protective effect of Hachimi-jio-gan against the development of pancreatic fibrosis and oxidative damage in Otsuka Long-Evans Tokushima Fatty rats. J Ethnopharmacol 2007; 113:91–99.
    1. Nakagawa T, Yokozawa T, Yamabe N, et al. Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats. J Pharm Pharmacol 2005; 57:1205–1212.
    1. Yamabe N, Yokozawa T. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus. J Pharm Pharmacol 2006; 58:535–545.
    1. Yokozawa T, Yamabe N, Cho EJ, et al. A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats. Nephron Exp Nephrol 2004; 97:e38–e48.
    1. Lin CJ, Su YC, Lee CH, et al. Bai-hu-tang, ancient chinese medicine formula, may provide a new complementary treatment option for sepsis. Evid Based Complement Alternat Med 2013; 2013:193084.
    1. Zhang S, Wang D, Wang X, et al. Aqueous extract of Bai-Hu-Tang, a classical Chinese herb formula, prevents excessive immune response and liver injury induced by LPS in rabbits. J Ethnopharmacol 2013; 149:321–327.
    1. Chen CC, Hsiang CY, Chiang AN, et al. Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang. J Ethnopharmacol 2008; 118:46–50.
    1. Kimura I, Nakashima N, Sugihara Y, et al. The antihyperglycaemic blend effect of traditional Chinese medicine Byakko-ka-ninjin-to on alloxan and diabetic KK-CA(y) mice. Phytother Res PTR 1999; 13:484–488.
    1. Niijima A, Kubo M, Ichiki H, et al. Effect of byakko-ka-ninjin-to on the efferent activity of the autonomic nerve fibers innervating the sublingual gland of the rat. J Auton Nerv Syst 1997; 63:46–50.
    1. Yanagi Y, Yasuda M, Hashida K, et al. Mechanism of salivary secretion enhancement by Byakkokaninjinto. Biol Pharm Bull 2008; 31:431–435.
    1. Pan CH, Hsieh IC, Liu FC, et al. Effects of a Chinese herbal health formula, “Gan-Lu-Yin”, on angiogenesis. J Agric Food Chem 2010; 58:7685–7692.
    1. Chien YC, Sheu MJ, Wu CH, et al. A Chinese herbal formula “Gan-Lu-Yin” suppresses vascular smooth muscle cell migration by inhibiting matrix metalloproteinase-2/9 through the PI3K/AKT and ERK signaling pathways. BMC Complement Altern Med 2012; 12:137.
    1. Huang Y, Jiang W, Xiao Y, et al. Multiobjective optimization on antiplatelet effects of three components combination by quantitative composition-activity relationship modeling and weighted-sum method. Chem Biol Drug Des 2014; 84:513–521.
    1. Liu L, Cheng Y, Zhang H. Phytochemical analysis of anti-atherogenic constituents of Xue-Fu-Zhu-Yu-Tang using HPLC-DAD-ESI-MS. Chem Pharm Bulletin (Tokyo) 2004; 52:1295–1301.
    1. Lin RT, Pai HC, Lee YC, et al. Electroacupuncture and rosiglitazone combined therapy as a means of treating insulin resistance and type 2 diabetes mellitus: a randomized controlled trial. Evid Based Complement Alternat Med 2013; 2013:969824.
    1. Ishizaki N, Okushi N, Yano T, et al. Improvement in glucose tolerance as a result of enhanced insulin sensitivity during electroacupuncture in spontaneously diabetic Goto-Kakizaki rats. Metabolism 2009; 58:1372–1378.
    1. Lee YC, Li TM, Tzeng CY, et al. Electroacupuncture-induced cholinergic nerve activation enhances the hypoglycemic effect of exogenous insulin in a rat model of streptozotocin-induced diabetes. Exp Diabetes Res 2011; 2011:947138.
    1. Lin RT, Chen CY, Tzeng CY, et al. Electroacupuncture improves glucose tolerance through cholinergic nerve and nitric oxide synthase effects in rats. Neurosci Lett 2011; 494:114–118.
    1. Choi S, Lee GJ, Chae SJ, et al. Potential neuroprotective effects of acupuncture stimulation on diabetes mellitus in a global ischemic rat model. Physiol Meas 2010; 31:633–647.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren